Presentation of an abstract at the American Urology Association (AUA2025) highlights Relmada's ongoing commitment to advancing treatment options in bladder cancer. Introduction of NDV-01 ...

A court decision has struck down a city of Austin ordinance that decriminalized ... is one of his "top five" bills in his time in the Texas legislature. The bill SB 3 has passed through the ...

April 28th AUA data presentation to highlight study in patients with high-grade non-muscle invasive bladder cancer ... honors from the University of Texas at Austin and Baylor College of Medicine ...

AUA data presentation to highlight study in patients with high-grade non-muscle invasive bladder cancer (HG-NMIBC) Virtual event to be held on April 28, 2025 at 4:30 PM ET CORAL GABLES, Fla., April 24 ...

Giulia Carbonaro is a Newsweek reporter based in London, U.K. Her focus is on the U.S. economy, housing market, property insurance market, local and national politics. She has previously ...

Terri Baker was diagnosed with stage 4 ovarian cancer in September. Today, the cancer is undetectable. When Terri Baker walked into an emergency room for blood in her urine, doctors diagnosed her ...

A dad who thought he had a UTI was diagnosed with stage four bladder cancer and given 24 months to live. Dad-of-two Chris Cotton, 50, started experiencing what he believed were UTI symptoms in ...

FDA approved Imfinzi with gemcitabine and cisplatin for muscle-invasive bladder cancer, based on NIAGARA trial results showing improved survival outcomes. The regimen integrates immunotherapy in pre- ...

Urothelial cancer is the most common type of bladder cancer (90 percent of cases) and can also be found in the renal pelvis (where urine collects inside the kidney), ureter (tube that connects the ...

Oral presentation provides update from QUILT-3.032 on durable complete responses to ANKTIVA ® plus BCG in BCG-unresponsive non-muscle invasive bladder cancer carcinoma in situ (NMIBC CIS ...

3 "Patients with bladder cancer need more effective treatment options that are both tolerable and easily incorporated into everyday practice, especially for those with HR-NMIBC, a highly recurrent ...

high-risk non-muscle invasive bladder cancer "Patients with bladder cancer need more effective treatment options that are both tolerable and easily incorporated into everyday practice, especially ...